Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy

Fig. 4

Kaplan–Meier survival analysis of overall survival and progression-free survival according to the optimum cut-offs of IBM scores. a Kaplan–Meier survival analysis of OS for the training cohort; b Kaplan–Meier survival analysis of PFS for the training cohort; c Kaplan–Meier survival analysis of OS for the validation cohort; d Kaplan–Meier survival analysis of PFS for validation cohort. We calculated the p value using the log-rank test. HR, hazard ratio; CI, confidence interval; IBM, imaging biomarker; OS, overall survival; PFS, progression-free survival

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us